Partner Highlights: July 2021

Blackford Analysis August 4, 2021

Here’s the latest instalment in our news updates from Blackford Platform Partners.

We are delighted to welcome AI diagnostics company Qlarity Imaging to the Blackford family, with the integration of Quant to our curated marketplace. QuantX delivers increased accuracy and improved reader performance benefits for breast MRI interpretation to help deliver better outcomes. The integration will feature the new cloud-based, vendor neutral format of QuantX, which is currently in development and pending application seeking FDA clearance. AI-powered breast health solution provider Densitas published an interview with Louise Miller, co-founder of Mammography Educators, about the impact of COVID-19 on mammography positioning and her perspective on the value of A.I. in breast screening. Lung analysis firm VIDA announced that the company will be exhibiting at HIMSS 2021. Go and check them out at Booth 5346. And finally, imaging AI specialist icometrix attended this year’s in-person edition of the AAIC21 conference, sharing and discussing its scientific poster on “Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer’s disease in a clinical setting”. The company also announced the release of the new version (1.3.0) of icompanion has been released, which includes the ability to add calendar appointments with reminders to patients to fill in a pre-visit checklist of which the answers are shared with the MS team. icometrix also announced the publication of a new paper in Human Brain Mapping, which assesses the typical and atypical cortical development during specific stages of reading. And the company was delighted to welcome healthcare futurist Professor Koen Kas for a fascinating keynote discussion on the 'Unknown Unknown' concept, which creates delight: cutting-edge exploits of digital health, from apps, devices, to our 'Digital Twin'. Stay tuned for more partner news next month!